Art

J-GLOBAL ID：202002235869033279   Reference number：20A2808467

Effect of two doses of botulinum toxin type A on maximum plantar contact area in hemiplegic stroke patients with pes equinovarus

内反尖足の片麻痺性脳卒中患者における最大足底接触面積に対するボツリヌス毒素A型2回投与の効果

Author (9)： Wada Yoshitaka (Department of Anatomy, School of Medicine, Showa University) ,  Wada Yoshitaka (Department of Rehabilitation Medicine, School of Medicine, Showa University) ,  Wada Yoshitaka (Showa University Fujigaoka Rehabilitation Hospital) ,  Otsuka Naruhito (Department of Anatomy, School of Medicine, Showa University) ,  Kawate Nobuyuki (Department of Rehabilitation Medicine, School of Medicine, Showa University) ,  Kawate Nobuyuki (Showa University Fujigaoka Rehabilitation Hospital) ,  Moriyama Hiroshi (Department of Anatomy, School of Medicine, Showa University) ,  Ezure Hiromitsu (Department of Anatomy, School of Medicine, Showa University) ,  Inoue Yuriko (Department of Anatomy, School of Medicine, Showa University)
Material： Japanese Journal of Comprehensive Rehabilitation Science (Web)  (Jpn J Compr Rehabil Sci (Web))
Volume： 11  Page： 85-90(J-STAGE)  Publication year： 2020 
JST Material Number： U0406A  ISSN： 2185-5323  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *Botulinum Toxin Type A ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2808467&from=J-GLOBAL&jstjournalNo=U0406A") }}

Author keywords (5)： spasticity ,  botulinum therapy ,  equinovarus ,  stroke ,  plantar contact area

JST classification (4)： Rehabilitation  (GB06000Z) ,  Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D) ,  Clinical neurology in general  (GN01030H) ,  Cardiovascular system diseases  (GJ03000C)

Reference (26)：

• 1. Lance JW. Symposium synopsis. in Spasticity: disordered motor control (ed. by Feldman RG, Young RR, Koella WP). Year Book Medical Publishers, Chicago 1980; 485-94.
• 2. Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35: 134-9.
• 3. Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin Rehabil 2002; 16: 515-22.
• 4. Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity and immunology. Muscle Nerve Suppl 1997; 6: 146-68.
• 5. Boyd RN. Pliatsios V, Starr R, Wolfe R, Graham HK. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2000; 42: 32-41.

Terms in the title (7)： 内反尖足 ,  片麻痺 ,  脳卒中患者 ,  足底 ,  接触面積 ,  ボツリヌス毒素A型 ,  投与